Reinhard Dummer

Researcher Next ID · RN-003826

Researcher · Biochemistry, Genetics and Molecular Biology

Zurich, Switzerland

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Melanoma and MAPK Pathways

Cutaneous Melanoma Detection and Management

Cancer Immunotherapy and Biomarkers

Cutaneous lymphoproliferative disorders research

CAR-T cell therapy research

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1910836
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709684
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1504030
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Science · 2015 · https://doi.org/10.1126/science.aad0095
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1103782

No projects listed.